Should Aphria (TSX:APHA) Investors Be Panicking Right Now?

Aphria Inc (TSX:APHA)(NYSE:APHA) has been in a free fall in the second half of 2019. Time to jump ship?

These past few months have been a rough ride for Aphria (TSX:APHA)(NYSE:APHA) investors. After reaching a peak closing price of $14.21 in February, the stock began sliding later that month, with the downtrend accelerating in April. By May 17, the stock was trading at just $9.19 — a 35% decline from its peak price.

The decline in Aphria’s share price comes after a brutal 2018 for the company, which saw it the target of short attacks, lawsuits, and even hostile takeover attempts. Earlier this year, it appeared that Aphria had brushed off the last of its woes, after Green Growth Brands announced that it was dropping its hostile bid against the company. Now, however, it looks like Aphria is facing a whole new — and potentially more troubling — set of problems.

Why Aphria stock is falling

Aphria’s stock selloff is likely related to uninspiring earnings figures that the company recently released. Although the gradual cooling off from February to April is hard to explain, the steeper April-June selloff occurred around the same time that the company released an earnings report showing that its recreational sales had been declining.

Specifically, the company reported 35% lower recreational pot revenue than it had in the prior quarter. Although the company’s revenue grew 600% year over year in that same quarter, a decline in recreational sales is a big concern, since this product category is the main catalyst expected to drive cannabis sales growth in the future. It’s also worth noting that in the same quarter Aphria posted a massive $108 million net loss, up from $12 million in the same quarter a year before.

Do the bears have a strong thesis?

Anybody who is bearish on Aphria right now has some strong facts to support their thesis. In addition to the already mentioned factors, there’s the fact that the company has been shaking up its management team — with the departure of CEO Vic Neufeld being a major point of contention. Although Aphria and Neufeld stated at the time that the resignation was not related to the issues the company was facing, the departure of a C-Suite executive with such timing always raises questions.

Reasons for optimism

There are some reasons for optimism about Aphria. With 600% year-over-year revenue growth, it’s one of the faster-growing cannabis companies. The company also has a lucrative long-term investment portfolio that, in past quarters, helped give it positive net income when other cannabis producers were losing money. Finally, Aphria has a strong international presence, including major operations in Columbia — a country where conditions are considered to be favourable for cannabis growing and cultivation.

Foolish takeaway

Aphria’s months-long downtrend has definitely been alarming but is not unusual for the cannabis sector. Remember, this industry has significantly more volatility than most, and every single cannabis grower out there has seen a 50% selloff at some point in the past three years. As for whether Aphria’s investors should be panicking, it depends on whether they’re able to handle that kind of volatility over the long term.

Fool contributor Andrew Button has no position in any of the stocks mentioned.

More on Cannabis Stocks

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Canopy Growth Stock Jumped 30% Last Month: What’s Going on?

Canopy Growth (TSX:WEED) stock is picking up traction again, making it an enticing weed play to buy on strength.

Read more »

A cannabis plant grows.
Cannabis Stocks

These Threats Facing Canopy Growth Stock Could Justify Selling it

Let's dive into whether Canopy Growth (TSX:WEED) is a top stock investors should buy right now after its recent dip…

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

This BioCannabis Firm Could Explode with Product Approval

This cannabis stock used to be a major name, so where does it stand now?

Read more »

Medicinal research is conducted on cannabis.
Stocks for Beginners

This TSX Health-Care Stock Is a Long-Term Buy for Patient Investors

This TSX stock continues to be one of the best long-term opportunities, if you're patient.

Read more »